As noted by TASS with reference to the company, the corresponding "appeal was sent."
It is noted that the vaccine being developed by Johnson & Johnson is effective when administered in a single dose.
Earlier Johnson & Johnson published preliminary data on the effectiveness of the vaccine against coronavirus infection COVID-19.